These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6086409)

  • 1. Molecular studies of the induction of cellular phospholipidosis by cationic amphiphilic drugs.
    Hostetler KY
    Fed Proc; 1984 Aug; 43(11):2582-5. PubMed ID: 6086409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of phospholipid storage induced by amantadine and chloroquine in Madin Darby canine kidney cells.
    Hostetler KY; Richman DD
    Biochem Pharmacol; 1982 Dec; 31(23):3795-9. PubMed ID: 7159462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lysosomal phospholipase A and phospholipase C by chloroquine and 4,4'-bis(diethylaminoethoxy) alpha, beta-diethyldiphenylethane.
    Matsuzawa Y; Hostetler KY
    J Biol Chem; 1980 Jun; 255(11):5190-4. PubMed ID: 6246100
    [No Abstract]   [Full Text] [Related]  

  • 4. Amiodarone- and desethylamiodarone-induced pulmonary phospholipidosis, inhibition of phospholipases in vivo, and alteration of [14C]amiodarone uptake by perfused lung.
    Kodavanti UP; Mehendale HM
    Am J Respir Cell Mol Biol; 1991 Apr; 4(4):369-78. PubMed ID: 2015101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cationic amphiphilic drugs on the hydrolysis of acidic and neutral phospholipids by liver lysosomal phospholipase A.
    Pappu A; Hostetler KY
    Biochem Pharmacol; 1984 May; 33(10):1639-44. PubMed ID: 6732837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural, physico-chemical and conformational study of the interactions of gentamicin and bis(beta-diethylaminoethylether) hexestrol with negatively-charged phospholipid layers.
    Mingeot-Leclercq MP; Schanck A; Ronveaux-Dupal MF; Deleers M; Brasseur R; Ruysschaert JM; Laurent G; Tulkens PM
    Biochem Pharmacol; 1989 Mar; 38(5):729-41. PubMed ID: 2539158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic basis of diethylaminoethoxyhexestrol-induced phospholipid fatty liver.
    Kubo M; Hostetler KY
    Am J Physiol; 1987 Mar; 252(3 Pt 1):E375-9. PubMed ID: 3030133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The induction of pulmonary phospholipidosis and the inhibition of lysosomal phospholipases by amiodarone.
    Heath MF; Costa-Jussà FR; Jacobs JM; Jacobson W
    Br J Exp Pathol; 1985 Aug; 66(4):391-7. PubMed ID: 2992568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological and biochemical changes in the liver of various species in experimental phospholipidosis after diethylaminoethoxyhexestrol treatment.
    de la Iglesia FA; Feuer G; McGuire EJ; Takada A
    Toxicol Appl Pharmacol; 1975 Oct; 34(1):28-44. PubMed ID: 1198614
    [No Abstract]   [Full Text] [Related]  

  • 10. Diethylaminoethoxyhexestrol inhibition of purified rat liver lysosomal phospholipase A1: role of drug binding to substrate.
    Kubo M; Hostetler KY
    J Pharmacol Exp Ther; 1987 Jan; 240(1):88-92. PubMed ID: 3027309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system.
    Sawada H; Takami K; Asahi S
    Toxicol Sci; 2005 Feb; 83(2):282-92. PubMed ID: 15342952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of kidney lysosomal phospholipases A and C by aminoglycoside antibiotics: possible mechanism of aminoglycoside toxicity.
    Hostetler KY; Hall LB
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1663-7. PubMed ID: 6951205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipidosis in the alveolar macrophage induced by cationic amphiphilic drugs.
    Reasor MJ
    Fed Proc; 1984 Aug; 43(11):2578-81. PubMed ID: 6745447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic amphiphilic drug-induced phospholipidosis.
    Halliwell WH
    Toxicol Pathol; 1997; 25(1):53-60. PubMed ID: 9061852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphiphilic cationic drugs and phospholipids influence the activities of beta-galactosidase and beta-glucosidase from liver lysosomal fraction of untreated rats.
    Harder A; Dodt G; Debuch H
    Biol Chem Hoppe Seyler; 1985 Feb; 366(2):189-93. PubMed ID: 2985099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloroquine treatment does not cause phospholipid storage by depleting rat liver lysosomes of acid phospholipase A.
    Reasor MJ; Hostetler KY
    Biochim Biophys Acta; 1984 May; 793(3):497-501. PubMed ID: 6712986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chloroquine and 4,4'-bis(diethylaminoethoxy)alpha, beta-diethyldiphenylethane on the incorporation of [3H]glycerol into the phospholipids of rat liver lysosomes and other subcellular fractions, in vivo.
    Matsuzawa Y; Hostetler KY
    Biochim Biophys Acta; 1980 Dec; 620(3):592-602. PubMed ID: 6263327
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunohistochemistry of LAMP-2 and adipophilin for phospholipidosis in liver and kidney in ketoconazole-treated mice.
    Asaoka Y; Togashi Y; Imura N; Sai T; Miyoshi T; Miyamoto Y
    Exp Toxicol Pathol; 2013 Sep; 65(6):817-23. PubMed ID: 23276623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for lysosomal phospholipase A2 in drug induced phospholipidosis.
    Abe A; Hiraoka M; Shayman JA
    Drug Metab Lett; 2007 Jan; 1(1):49-53. PubMed ID: 19356018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipidosis effect of drugs by adsorption into lipid monolayers.
    Ceccarelli M; Germani R; Massari S; Petit C; Nurisso A; Wolfender JL; Goracci L
    Colloids Surf B Biointerfaces; 2015 Dec; 136():175-84. PubMed ID: 26387069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.